The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...

Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus ...

Morning. Today, we examine the plush pay packages of health care’s top CEOs in 2024. Also, we discuss Stealth BioTherapeutics ...

Cambridge-based rejuvenation biology company developing therapies to reverse ageing and extend healthspan, has fortified its leadership team with a key hire. The company has brought in former BioNTech ...

BioNTech, and Novavax targeting the LP.8.1 sublineage of SARS-CoV-2, with eligibility limited to adults aged 65 years and ...

MAINZ, Germany, August 4, 2025-- BioNTech SE today reported financial results for the six months ended June 30, 2025 and provided an update on its corporate progress. "In the second quarter, we ...